Positive HCMV DNAemia in stem cell recipients undergoing letermovir prophylaxis is expression of abortive infection
Authors:
- Irene CassanitiICIrene Cassaniti
- Anna Amelia ColomboACAnna Amelia Colombo
- Paolo BernasconiPBPaolo Bernasconi
- Michele MalagolaMMMichele Malagola
- Domenico RussoDRDomenico Russo
- Anna Paola IoriAIAnna Paola Iori
- Corrado GirmeniaCGCorrado Girmenia
- Raffaella GrecoRGRaffaella Greco
- Jacopo PeccatoriJPJacopo Peccatori
- Fabio CiceriFCFabio Ciceri
- Francesca BonifaziFBFrancesca Bonifazi
- Elena PercivalleEPElena Percivalle
Open Access
- 15 December 2020
- journal article
- research article
- Published by Elsevier in American Journal of Transplantation
- Vol. 21 (4) , 1622-1628
Abstract
No abstract availableKeywords
Funding Information
- Fondazione IRCCS Policlinico San Matteo (80720, 80207)
This publication has 18 references indexed in Scilit:
- Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell TransplantationNew England Journal of Medicine, 2017
- Determination of the Biological Form of Human Cytomegalovirus DNA in the Plasma of Solid-Organ Transplant RecipientsThe Journal of Infectious Diseases, 2017
- Valganciclovir for the Prevention of Complications of Late Cytomegalovirus Infection After Allogeneic Hematopoietic Cell TransplantationAnnals of Internal Medicine, 2015
- Kinetics of human cytomegalovirus (HCMV) DNAemia in transplanted patients expressed in international units as determined with the Abbott RealTime CMV assay and an in-house assayJournal of Clinical Virology, 2012
- The Novel Anticytomegalovirus Compound AIC246 (Letermovir) Inhibits Human Cytomegalovirus Replication through a Specific Antiviral Mechanism That Involves the Viral TerminaseJournal of Virology, 2011
- In Vitro and In Vivo Activities of the Novel Anticytomegalovirus Compound AIC246Antimicrobial Agents and Chemotherapy, 2010
- Impact of human metapneumovirus and human cytomegalovirus versus other respiratory viruses on the lower respiratory tract infections of lung transplant recipientsJournal of Medical Virology, 2006
- In Vitro Model for the Study of the Dissociation of Increasing Antigenemia and Decreasing DNAemia and Viremia during Treatment of Human Cytomegalovirus Infection with Ganciclovir in Transplant RecipientsThe Journal of Infectious Diseases, 2003
- In vitro generation of human cytomegalovirus pp65 antigenemia, viremia, and leukoDNAemia.Journal of Clinical Investigation, 1998
- Preemptive Therapy in Immunocompromised HostsNew England Journal of Medicine, 1991